Abstract
Studies have shown that the renin-angiotensin system (RAS) plays an important role in cardiac remodeling induced by hypertension. However, the role of this system on myocyte remodeling remains unclear. In the present study, we have assessed the effect of perindopril, an angiotensin converting enzyme (ACE) inhibitor, in spontaneously hypertensive rats (SHRs) as a means to evaluate the role of RAS in myocyte remodeling. We also investigated the effect of beta blockade on myocyte remodeling. We used female SHRs at 12 weeks of age. They were divided into four experimental groups: a control group, group C; low dose perindopril group (0.3 mg/kg/day, p.o.), group PL; high dose perindopril group (3 mg/kg/day, p.o.), group PH; and bisoprolol group (60 mg/kg/day, p.o.), group B. We isolated myocytes from these rats after 4 weeks. LV myocyte volume and cross-sectional area decreased in groups PL and PH compared to group C. LV myocyte length decreased in group PH compared to group C. However, there was no morphological change in LV myocytes in group B compared to group C. In summary, ACE inhibitors reversed cardiac hypertrophy mainly by a reduction in LV myocyte volume; however, beta blockade did not reverse myocyte remodeling. These resul...Continue Reading
References
Jul 1, 1975·The Journal of Clinical Investigation·W GrossmanL P McLaurin
Feb 1, 1978·Circulation Research·K RakusanB Korecky
Jan 1, 1992·Life Sciences·K MizunoS Fukuchi
Jan 1, 1992·Clinical and Experimental Pharmacology & Physiology. Supplement·T Morgan, A Anderson
Feb 1, 1992·American Journal of Hypertension·B DahlöfL Hansson
May 31, 1990·The New England Journal of Medicine·D LevyW P Castelli
Dec 1, 1990·Hypertension·S B HarrapA F Lever
Mar 1, 1986·Journal of Cardiovascular Pharmacology·T UngerR E Lang
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·W LinzD Ganten
Aug 1, 1987·Circulation·F G DunnE D Frohlich
Dec 1, 1983·The Anatomical Record·I K Lauva, R J Tomanek
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Apr 1, 1995·Hypertension·N K ThyboM J Mulvany
May 15, 1995·Circulation·S E LitwinP S Douglas
Sep 1, 1994·Japanese Heart Journal·Y SugishitaI Yamaguchi
May 1, 1994·Circulation·M KojimaT Kadowaki
Sep 1, 1993·Circulation Research·J Sadoshima, S Izumo
Mar 1, 1993·Clinical and Experimental Pharmacology & Physiology·F NakamuraT Ogihara
Feb 1, 1996·Journal of the American College of Cardiology·A LaserG Ertl
Oct 1, 1996·Hypertension·A M GerdesS A McCune
Jan 27, 1998·Circulation·P VerdecchiaC Porcellati
Oct 17, 1998·Hypertension·T OnoderaA M Gerdes
Mar 6, 1999·Journal of Hypertension
Apr 30, 1999·Hypertension Research : Official Journal of the Japanese Society of Hypertension·R B Devereux, M J Roman
Jul 13, 2000·Circulation·T TamuraA M Gerdes
Dec 29, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·T Kai, K Ishikawa
Citations
Aug 26, 2004·Neurological Research·R KurosakiT Araki
Dec 18, 2004·Heart·J E ToblliP Forcada
Jun 3, 2009·European Heart Journal·Nazha HamdaniJolanda van der Velden
Jan 31, 2016·Medical Hypotheses·Begoña Quintana-Villamandos, Emilio Delgado-Baeza
Jul 22, 2008·The American Journal of Medicine·L Michael Prisant
Dec 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rumiko KurosakiTsutomu Araki
Nov 19, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Nan JiaAkira Kitabatake
Mar 18, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hongzhuan ShengJinan Zhang
Oct 22, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shingo SekiSeibu Mochizuki
Jul 30, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Wen Qiang ChenYun Zhang
Oct 16, 2012·Journal of Cardiovascular Pharmacology·Can ChenZhi-Gen Li
May 23, 2009·Journal of Hypertension·Amal M Ziada